Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GMP webcast

This article was originally published in The Tan Sheet

Executive Summary

National Nutritional Foods Association is poised to analyze long-awaited supplement good manufacturing practices when FDA publishes a final rule "at any time," the group says. NNFA plans to hold a web conference "within 72 hours of the rule's publication to discuss key legal and regulatory aspects of the rule" in order to "help industry better understand the impact of the final regulation." For information, visit NNFA's 1website. CFSAN Director Robert Brackett said in May the agency is aiming to release the final rule by the end of the year (2"The Tan Sheet" May, 10, 2004, p. 16)...

National Nutritional Foods Association is poised to analyze long-awaited supplement good manufacturing practices when FDA publishes a final rule "at any time," the group says. NNFA plans to hold a web conference "within 72 hours of the rule's publication to discuss key legal and regulatory aspects of the rule" in order to "help industry better understand the impact of the final regulation." For information, visit NNFA's 1 website. CFSAN Director Robert Brackett said in May the agency is aiming to release the final rule by the end of the year (2 (Also see "CFSAN’s Brackett Says Supplement GMPs Remain Top Priority" - Pink Sheet, 10 May, 2004.), p. 16)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097245

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel